Cargando…
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
While suppression of specific genes through aberrant promoter methylation contributes to different diseases including organ fibrosis, gene-specific reactivation technology is not yet available for therapy. TET enzymes catalyze hydroxymethylation of methylated DNA, reactivating gene expression. We he...
Autores principales: | Xu, Xingbo, Tan, Xiaoying, Tampe, Björn, Wilhelmi, Tim, Hulshoff, Melanie S., Saito, Shoji, Moser, Tobias, Kalluri, Raghu, Hasenfuss, Gerd, Zeisberg, Elisabeth M., Zeisberg, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115451/ https://www.ncbi.nlm.nih.gov/pubmed/30158531 http://dx.doi.org/10.1038/s41467-018-05766-5 |
Ejemplares similares
-
CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications
por: Xu, Xingbo, et al.
Publicado: (2020) -
Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1
por: Wilhelmi, Tim, et al.
Publicado: (2020) -
Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease
por: Tampe, Björn, et al.
Publicado: (2014) -
Low levels of circulating methylated IRX3 are related to worse outcome after transcatheter aortic valve implantation in patients with severe aortic stenosis
por: Kanwischer, Leon, et al.
Publicado: (2023) -
DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition
por: Tan, Xiaoying, et al.
Publicado: (2016)